Goel, who comes to Cipla from GlaxoSmithKline (GSK), will be reporting to company's Managing Director and Global CEO Subhanu Saxena.
"This appointment signals the continuation of Cipla's strategy of strengthening the highly experienced senior management team and showing our strong determination to increase the market share in India," Saxena said in a statement.
Also Read
"This, combined with his strong reputation for managing teams for stakeholders - both external and internal - makes him well placed to lead our India business into its next level of growth," Saxena said.
Goel, in his last assignment, led a $0.4 billion business based out of Johannesburg, with responsibility for 44 markets in Sub-Saharan Africa.
In his last India-based role at GSK, he led the sales team comprising 4,500 direct and indirect field executives.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)